BIO-Key International Inc reports results for the quarter ended December 31 - Earnings Summary
27/03/2025 13:31
BIO-Key International Inc BKYI.OQ reported a quarterly adjusted loss of 53 cents per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of $-8.41. The lone analyst forecast for the quarter was for a loss of 35 cents per share. Revenue was $1.46 million; analysts expected $2.29 million. The company reported a quarterly loss of $1.57 million. BIO-Key International Inc shares had fallen by 34.5% this quarter. FORECAST CHANGES The mean earnings estimate of analysts was unchanged in the last three months. In the last 30 days, there have been no earnings estimate revisions by analysts covering the company. RECOMMENDATIONS The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the electronic equipment & parts peer group is also "buy" Wall Street's median 12-month price target for BIO-Key International Inc is $3.00 This summary was machine generated from LSEG data March 27 at 01:30 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
| QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
| Dec. 31 2024 | -0.35 | -0.53 | Missed |
| Sep. 30 2024 | -0.58 | -0.39 | Beat |
| Jun. 30 2024 | -0.54 | -1.00 | Missed |